Stock TRA TRAPHACO
Add to a list
To use this feature you must be a member
Log inSign up

Financials Traphaco

Equities

TRA

VN000000TRA8

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
80,900 VND -0.12% Intraday chart for Traphaco -0.61% -9.10%
26/04 Traphaco Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
17/04 Traphaco Joint Stock Company Announces Board Changes CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 25,07,758 29,67,859 37,80,289 36,89,098 36,89,098 33,53,349
Enterprise Value (EV) 1 25,07,758 29,67,859 37,80,289 36,89,098 36,89,098 33,53,349
P/E ratio 18.5 x 17.1 x - - - -
Yield - - - - - 3.71%
Capitalization / Revenue 1.46 x - 1.74 x 1.54 x 1.61 x 1.31 x
EV / Revenue 1.46 x - 1.74 x 1.54 x 1.61 x 1.31 x
EV / EBITDA - - - - 8.12 x 6.54 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - - 2.9 x 2.68 x 2.12 x
Nbr of stocks (in thousands) 41,451 41,451 41,451 41,451 41,451 41,451
Reference price 2 60,500 71,600 91,200 89,000 89,000 80,900
Announcement Date 03/03/20 25/03/21 27/01/22 31/01/23 30/01/24 -
1VND in Million2VND
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 17,16,062 - 21,76,276 23,98,918 22,96,644 25,55,000
EBITDA 1 - - - - 4,54,086 5,13,000
EBIT 1 - - - - 3,59,456 4,10,000
Operating Margin - - - - 15.65% 16.05%
Earnings before Tax (EBT) - - - - - -
Net income - 1,95,787 - - - -
Net margin - - - - - -
EPS 3,269 4,185 - - - -
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - - - - 3,000
Announcement Date 03/03/20 25/03/21 27/01/22 31/01/23 30/01/24 -
1VND in Million2VND
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - - 22.1% 18.8% 19.9%
ROA (Net income/ Total Assets) - - - 15.3% 14% 15.7%
Assets - - - - - -
Book Value Per Share 1 - - - 30,667 33,204 38,076
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 03/03/20 25/03/21 27/01/22 31/01/23 30/01/24 -
1VND
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
80,900 VND
Average target price
95,300 VND
Spread / Average Target
+17.80%
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
TRAPHACO Stock Traphaco
-9.10% 132M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.27% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.58% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.00% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.16% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.67% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TRA Stock
  4. Financials Traphaco
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW